Breaking News

UniSafe Device Drives Biosimilar Success in Japan

The success of NIPRO’s biosimilar product, launched in late 2023, has exceeded expectations and gained significant market share.

Author Image

By: Charlie Sternberg

Associate Editor

Owen Mumford’s exclusive agreement with Osaka-based NIPRO CORPORATION to distribute drug delivery device UniSafe has achieved rapid early growth in combination product sales in Japan. The agreement has been in place since 2019 and has scored a major new product launch success in delivering a biosimilar product used with cancer medicines into the Japanese market. Since the launch of the product in late 2023, it has already acquired a considerable share of its market in Japan, including the ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters